Von hippel-lindau disease and erythrocytosis

J Clin Oncol. 2012 May 1;30(13):e137-9. doi: 10.1200/JCO.2011.38.6797. Epub 2012 Mar 5.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / genetics
  • Adult
  • Anticoagulants / therapeutic use
  • Aspirin / administration & dosage
  • Biomarkers / blood
  • Biopsy
  • DNA Mutational Analysis
  • Erythropoietin / blood
  • Genetic Predisposition to Disease
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Mutation
  • Pedigree
  • Phenotype
  • Pheochromocytoma / genetics
  • Phlebotomy
  • Polycythemia / blood
  • Polycythemia / genetics*
  • Polycythemia / therapy
  • Treatment Outcome
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics*
  • von Hippel-Lindau Disease / blood
  • von Hippel-Lindau Disease / complications
  • von Hippel-Lindau Disease / genetics*

Substances

  • Anticoagulants
  • Biomarkers
  • Erythropoietin
  • Von Hippel-Lindau Tumor Suppressor Protein
  • VHL protein, human
  • Aspirin